业绩预告
Search documents
西藏天路股份有限公司 2025年度业绩预告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2026-01-28 23:26
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示: ● 本期业绩预告适用于年度净利润为负值的情形。 2025年1月1日至2025年12月31日 (二)业绩预告情况 经财务部门初步测算,预计2025年度实现归属于上市公司股东的净利润为-7,900.00万元到-5,600.00万 元,与上年同期(法定披露数据)相比,预计减亏2,528.22万元到4,828.22万元,同比减亏24.24%到 46.30%。 ● 西藏天路股份有限公司(以下简称"公司")预计2025年度实现归属于上市公司股东的净利润 为-7,900.00万元到-5,600.00万元,与上年同期(法定披露数据)相比,预计减亏2,528.22万元到4,828.22 万元,同比减亏24.24%到46.30%。 ● 公司预计2025年度归属于上市公司股东的扣除非经常性损益的净利润为-12,000.00万元到-9,700.00万 元,与上年同期(法定披露数据)相比,预计亏损减少1,676.66万元到3,976.66万元,同比减亏12.26% 到29.08%。 一、本 ...
天圣制药集团股份有限公司 2025年度业绩预告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2026-01-28 23:21
Group 1 - The company expects a net loss for the fiscal year 2025, with the performance forecast period from January 1, 2025, to December 31, 2025 [1] - The financial data related to the performance forecast has not been audited by the accounting firm, but preliminary communication indicates no significant discrepancies [1][2] Group 2 - The primary reason for the expected loss is high fixed costs, particularly depreciation expenses on fixed assets [2] - The company anticipates a reduction in losses compared to the previous year, mainly due to a decrease in the provision for impairment of fixed assets [2]
华映科技(集团)股份有限公司 2025年度业绩预告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2026-01-28 23:21
2025年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗 漏。 一、本期业绩预计情况 1、业绩预告期间:2025年1月1日–2025年12月31日 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:000536 证券简称:华映科技 公告编号:2026-003 华映科技(集团)股份有限公司 三、业绩变动原因说明 本报告期,显示面板行业竞争依然激烈,公司聚焦主业,积极拓展市场,优化产品结构,提升管理效 率,通过整合生产线、压降材料成本及优化资源配置等多项措施改善产品成本,使得面板产品毛利得到 提升。与上年同期相比,公司本报告期净利润同比增长。 四、其他相关说明 1、本次业绩预告是公司财务部门初步测算的结果,未经审计机构审计。 2、公司2025年度具体财务数据请以公司正式披露的2025年年度报告为准,敬请广大投资者谨慎决策, 注意投资风险。 特此公告! 华映科技(集团)股份有限公司 董事会 2、业绩预告情况:预计净利润为负值 ■ 二、与会计师事务所沟通情况 本次业绩预告相关财务数据是公司财务部门初步测算的结果,尚未经会计师事务所审计。公司已就本次 业 ...
浙江钱江摩托股份有限公司2025年度业绩预告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2026-01-28 23:11
Group 1 - The company has provided a voluntary performance forecast for the period from January 1, 2025, to December 31, 2025, indicating expected financial results [1] - The forecasted net profit attributable to shareholders is expected to increase primarily due to non-recurring gains, which are projected to rise by approximately 585 million yuan compared to the same period last year [1] - The anticipated pre-tax profit from "asset disposal gains" for 2025 is estimated at 850 million yuan, significantly higher than the 126 million yuan reported in the same period last year [1] Group 2 - The company has communicated with its auditing firm regarding the performance forecast, and there are no significant discrepancies between the company and the auditors concerning the forecast data [1] - The net profit, excluding non-recurring gains, is expected to decline year-on-year, primarily due to a decrease in motorcycle sales during the reporting period [1]
北京昊华能源股份有限公司 2025年度业绩预告
Zheng Quan Ri Bao· 2026-01-28 23:07
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:601101 证券简称:昊华能源 公告编号:2026-003 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: ● 业绩预告的具体适用情形:实现盈利,且净利润与上年同期相比下降50%以上。 ● 北京昊华能源股份有限公司(以下简称"公司")预计2025年度实现归属于母公司所有者的净利润 41,929万元到56,929万元,与上年同期(法定披露数据)相比,将减少61,728万元到46,728万元,同比减 少59.55%到45.08%。 ● 公司预计2025年度实现归属于母公司所有者的扣除非经常性损益的净利润39,131万元到54,131万元, 与上年同期(法定披露数据)相比,将减少63,504万元到48,504万元,同比减少61.87%到47.26%。 一、本期业绩预告情况 (一)业绩预告期间 2025年1月1日至2025年12月31日 (二)业绩预告情况 经财务部门初步测算,预计2025年度实现归属于母公司所有者的净利润41,929万元到56,929 ...
深圳赛格股份有限公司 2025年度业绩预告
Zheng Quan Ri Bao· 2026-01-28 22:56
Group 1 - The company expects to report a net profit increase for the year 2025, primarily due to the sale of shares in Shenzhen Huakong Saige Co., Ltd., which generated an investment income of approximately 37 million yuan, a significant change from 2024 when there was no such income [4] - The company will include the financial statements of Shenzhen 863 New Materials Technology Co., Ltd. in its consolidated reports for 2025 following the acquisition of 81% of its shares from Shenzhen Tongchan Lixing Technology Group Co., Ltd. [2] - The company has communicated with its accounting firm regarding the performance forecast, and there are no discrepancies between the two parties concerning the forecast [3] Group 2 - The company's net profit, excluding non-recurring gains and losses, is expected to decline due to changes in asset impairment factors, leading to a contraction in net profit year-on-year [4] - The company is involved in a significant lawsuit through its subsidiary, Shenzhen Saige New City Development Co., Ltd., with claims amounting to approximately 122.36 million yuan, which could adversely affect the company's 2025 performance if the court rules in favor of the opposing party [6][8] - The company has not yet received a ruling on the case and acknowledges the uncertainty regarding the timing and outcome of the trial, which may impact the company's financial results [8]
蓝黛科技集团股份有限公司 2025年度业绩预告
Zheng Quan Ri Bao· 2026-01-28 22:31
Group 1 - The company expects a positive net profit for the fiscal year 2025, indicating a significant performance improvement compared to the previous year [1] - The performance forecast period is from January 1, 2025, to December 31, 2025 [1] - The company has communicated with the accounting firm regarding the performance forecast, and there are no significant disagreements between the two parties [1] Group 2 - The substantial growth in the company's performance is attributed to the enhancement of production capacity and product quality in the power transmission business, focusing on core components for new energy vehicles [1] - In the touch display business, the company has been actively expanding its customer base and improving product gross margins in areas such as cover glass, display modules, and automotive touch screens [1]
业绩预告前股价“抢跑式”跌停!沃尔核材预计2025年净利润不及机构预期
Mei Ri Jing Ji Xin Wen· 2026-01-28 22:15
Core Viewpoint - The company,沃尔核材, forecasts a net profit attributable to shareholders of 1.1 billion to 1.18 billion yuan for 2025, representing a year-on-year growth of 29.79% to 39.22%, but this is below the consensus estimate of 1.263 billion yuan from five institutions [2][5][6] Financial Performance - The expected net profit for 2025 is between 1.1 billion and 1.18 billion yuan, compared to approximately 848 million yuan in the previous year [2][3] - The forecasted net profit after deducting non-recurring gains is estimated at 1.036 billion to 1.111 billion yuan, also reflecting a growth of 29.79% to 39.22% year-on-year [2][3] - Basic earnings per share are projected to be between 0.8825 yuan and 0.9467 yuan, up from 0.68 yuan per share in the previous year [2][3] Market Reaction - Following the earnings forecast announcement, the company's stock experienced a significant drop, hitting the daily limit down with a trading volume of 5.484 billion yuan and a turnover rate of 17.23% [7] - There was a notable increase in trading volume prior to the earnings announcement, leading to a sharp decline in stock price [7] Business Segments and Growth Drivers - The company attributes its expected performance improvement to rising market demand in electronic materials, communication cables, power products, and new energy vehicle products [4] - The communication cable and new energy vehicle segments are experiencing rapid growth due to increased demand from downstream industries and supportive industrial policies [4][5] Future Plans - The company has submitted an application for a secondary listing in Hong Kong, aiming to raise funds for global business expansion, capacity enhancement in China and Malaysia, potential strategic investments or acquisitions, and general corporate purposes [8]
贵阳新天药业股份有限公司2025年度业绩预告
Shang Hai Zheng Quan Bao· 2026-01-28 19:19
Group 1 - The company Guizhou Xintian Pharmaceutical Co., Ltd. expects a net profit decrease of over 50% for the fiscal year 2025, with the performance forecast period from January 1, 2025, to December 31, 2025 [1][2] - The decline in revenue is attributed to market conditions and rising raw material costs, which have impacted production costs [2] - The company plans to optimize its management and marketing strategies to enhance market development and reduce cost pressures from raw material price increases [2] Group 2 - The company has approved the transfer of drug marketing licenses and related production technologies for four products to Guizhou Xinan Tang Group Pharmaceutical Co., Ltd. for a total of RMB 14 million [8][12] - The products being transferred include "Nalejing Granules," "Nalejing Capsules," "Cold Cough Capsules," and "Regulating Blood Capsules," with individual transfer prices of RMB 3 million for each of the first three products and RMB 5 million for the last [12][25][26][27][28] - This transaction is aimed at optimizing the company's product pipeline and focusing on core strategic varieties, which will help in revitalizing existing assets [36]
浙商中拓集团股份有限公司2025年度业绩预告
Shang Hai Zheng Quan Bao· 2026-01-28 19:09
Group 1 - The company expects a decline in net profit for the year 2025, despite achieving a significant increase in operational volume, which is projected to exceed 150 million tons, representing a year-on-year growth of over 40% [2][3] - The decrease in net profit is attributed to a slowdown in the overall industry chain turnover and a decline in operating profits from industrial clients [2] - The company has engaged in hedging activities using futures and other derivative tools to manage price and exchange rate risks, which resulted in non-recurring losses that are closely related to its core business operations [2] Group 2 - The company plans to invest in the restructuring of certain assets of Jiangsu Delong Nickel Industry Co., Ltd. and 30 other companies, with the investment requiring approval from the board and relevant authorities [3] - The preliminary financial data for the performance forecast has not been audited by an accounting firm, and the final audited annual report will provide the definitive figures [3]